Bank Of America Corp Meridian Bioscience Inc Transaction History

Bank Of America Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$31.15 - $33.39 $1.39 Million - $1.49 Million	44,767 Added 60.77%	118,438 $3.93 Million
Q3 2022 Nov 14, 2022	SELL	$30.9 - $33.55 $279,799 - $303,795	-9,055 Reduced 10.95%	73,671 $2.32 Million
Q2 2022 Aug 12, 2022	BUY	$23.75 - $31.69 $283,978 - $378,917	11,957 Added 16.9%	82,726 $2.52 Million
Q1 2022 May 16, 2022	SELL	$19.97 - $26.94 $1.33 Million - $1.79 Million	-66,375 Reduced 48.4%	70,769 $1.84 Million
Q4 2021 Feb 08, 2022	BUY	$17.46 - $21.61 $1.6 Million - $1.98 Million	91,730 Added 201.99%	137,144 $2.8 Million
Q3 2021 Nov 15, 2021	SELL	$17.35 - $22.5 $1.72 Million - $2.23 Million	-99,273 Reduced 68.61%	45,414 $873,000
Q2 2021 Sep 13, 2021	BUY	$18.01 - $28.32 $2.61 Million - $4.1 Million	144,687 New	144,687 $3.21 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.